Grassi Investment Management Bristol Myers Squibb CO Transaction History

Grassi Investment Management

$1.16 Billion
Q3 2024

A detailed history of Grassi Investment Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Grassi Investment Management holds 108,360 shares of BMY stock, worth $6.07 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

108,360

Previous 108,760 0.37%

Holding current value

$6.07 Million

Previous $4.52 Million 24.13%

% of portfolio

0.48%

Previous 0.4%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$39.66 - $51.75 $15,863 - $20,700	-400 Reduced 0.37%	108,360 $5.61 Million
Q2 2024 Jul 09, 2024	SELL	$40.25 - $52.99 $4,025 - $5,299	-100 Reduced 0.09%	108,760 $4.52 Million
Q4 2023 Jan 10, 2024	BUY	$48.48 - $57.85 $14,543 - $17,355	300 Added 0.28%	108,860 $5.59 Million
Q2 2023 Jul 11, 2023	SELL	$63.71 - $70.74 $108,307 - $120,257	-1,700 Reduced 1.54%	108,560 $6.94 Million
Q1 2023 Apr 11, 2023	BUY	$65.71 - $74.53 $111,706 - $126,701	1,700 Added 1.57%	110,260 $7.64 Million
Q1 2022 Apr 12, 2022	BUY	$61.48 - $73.72 $110,664 - $132,696	1,800 Added 1.69%	108,560 $7.93 Million
Q4 2021 Jan 13, 2022	SELL	$53.63 - $62.52 $32,178 - $37,512	-600 Reduced 0.56%	106,760 $6.66 Million
Q2 2021 Jul 09, 2021	SELL	$61.91 - $67.42 $2.01 Million - $2.19 Million	-32,422 Reduced 23.19%	107,360 $7.17 Million
Q1 2021 Apr 12, 2021	SELL	$59.34 - $66.74 $194,219 - $218,440	-3,273 Reduced 2.29%	139,782 $8.82 Million
Q4 2020 Jan 19, 2021	SELL	$57.74 - $65.43 $799,583 - $906,074	-13,848 Reduced 8.83%	143,055 $8.87 Million
Q3 2020 Oct 13, 2020	BUY	$57.43 - $63.64 $139,325 - $154,390	2,426 Added 1.57%	156,903 $9.46 Million
Q2 2020 Jul 15, 2020	BUY	$54.82 - $64.09 $63,152 - $73,831	1,152 Added 0.75%	154,477 $9.08 Million
Q1 2020 Apr 08, 2020	BUY	$46.4 - $67.43 $748,664 - $1.09 Million	16,135 Added 11.76%	153,325 $8.55 Million
Q4 2019 Jan 10, 2020	BUY	$49.21 - $64.19 $178,386 - $232,688	3,625 Added 2.71%	137,190 $8.81 Million
Q3 2019 Oct 04, 2019	BUY	$42.77 - $50.71 $440,531 - $522,313	10,300 Added 8.36%	133,565 $6.77 Million
Q2 2019 Jul 10, 2019	BUY	$44.62 - $49.34 $2.31 Million - $2.56 Million	51,849 Added 72.6%	123,265 $5.59 Million
Q2 2018 Jul 10, 2018	SELL	$50.53 - $62.98 $653,858 - $814,961	-12,940 Reduced 15.34%	71,416 $3.95 Million
Q1 2018 Apr 10, 2018	BUY	$59.92 - $68.98 $149,800 - $172,450	2,500 Added 3.05%	84,356 $5.34 Million
Q4 2017 Jan 10, 2018	BUY	$59.94 - $65.35 $8,991 - $9,802	150 Added 0.18%	81,856 $5.02 Million
Q3 2017 Oct 10, 2017	BUY	$55.23 - $63.74 $4.51 Million - $5.21 Million	81,706	81,706 $5.21 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grassi Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Grassi Investment Management with notifications on news.

Account

Grassi Investment Management Bristol Myers Squibb CO Transaction History